Clinical Trial Update: Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating adding Lu AE58054 to donepezil for moderate Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)
• Lu AE58054

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED